Moorfields Eye Hospital Dubai (Moorfields) has announced the appointment of a new Consultant Paediatric Ophthalmologist specialising in children’s eye diseases, strabismus (squint) and cataract surgery for children.
Dr. Namir Kafil-Hussain is an experienced consultant ophthalmic surgeon and has held senior clinical consulting roles in some of the leading specialist hospitals in the UK and Republic of Ireland, managing high quality paediatric ophthalmic services. His work encompasses all aspects of eye surgery for children including small incision cataract surgery, intraocular lens implantation, squint surgery and botulinum toxin injection for treatment of squint. He has screened and performed laser treatment on premature babies (Retinopathy of Prematurity – ROP) as early as 23 weeks, as well as publishing research on ROP prevention and treatment trends.
Dr. Namir trained at centres of excellence in ophthalmology, including Oxford, London and Dublin, and completed his specialist training at the Royal College of Ophthalmologists. He has lectured, researched and published extensively on his specialist areas of interest, including original clinical papers related to Children’s Eye Diseases, Strabismus (Squints) and Cataract surgery. He is a Fellow of the Royal College of Surgeons of Edinburgh; Fellow of the Royal College of Ophthalmologists; and is a member of the United Kingdom and Ireland Society of Cataract and Refractive Surgery.
Dr. Ammar Safar, Medical Director of Moorfields Eye Hospital Dubai, commented: “At Moorfields Dubai, we pride ourselves on our unique capacity to treat the most complex eye conditions, including those affecting children, who comprise a significant proportion of our patients. Dr. Namir brings exceptional skills and experience to the paediatric team, which provides a comprehensive service to younger patients by covering the full range of advanced medical and surgical services including the most challenging cases, even in premature babies.”
Moorfields Eye Hospital Dubai (MEHD) is the first overseas branch of Moorfields Eye Hospital NHS Foundation Trust, the oldest and one of the largest centres for ophthalmic treatment, teaching and research in the world. Located at the Al Razi Medical Complex in Dubai Health Care City, the facility provides day case surgery and outpatient diagnostic and treatment services, for a variety of surgical and non-surgical eye conditions. MEHD will also raise standards for research and teaching in the region. MEHD is owned and managed by the NHS Foundation Trust, and maintains close links with London, to ensure that patients in the GCC receive the best eye care treatment in the world.
SOURCE Moorfields Eye Hospital Dubai
Breaking Ground on Europe’s Largest Hemp Extraction Facility
Precision Extraction Solutions Named Exclusive Equipment Supplier of Canapar S.r.L.
Precision Extraction Solutions (“Precision”), a market leader in cannabis and hemp extraction technology, has been named the exclusive equipment supplier of Canapar S.r.L. (“Canapar”) for the development and outfitting of its flagship extraction facility in Sicily, Italy.
On the heels of a $25 million CAD ($20 million USD) round of financing, that included a lead investment by Canopy Rivers Inc (TSXV: RIV), the corporate venture capital platform of Canopy Growth Corporation (TSX: WEED, NYSE: CGC), a global leader in the cannabis sector, Canapar engaged Precision for the design and manufacturing of an industrial scale hemp extraction plant.
“The KPD series extraction plant represents the newest and most innovative extraction technology in the marketplace. We are excited to see this revolutionary and automated cGMP solution at Canapar’s state-of-the-art facility,” states Nick Tennant, CTO of Precision.
The Precision® KPD Series is a scalable solution for industrial and agri-processing demands ranging from 2,200 lbs (1,000 kilograms) of cannabis or hemp input material per day to more than 100,000+ lbs per day.
Canapar’s Ragusa, Sicily facility, outfitted with a KPD series extraction plant, is expected to produce CBD extracts and isolate, which will then be used for a wide range of health and beauty, cosmetics, pharmaceutical and veterinary products.
“We chose Precision as our extraction technology partner because they are the most recognized and innovative extraction equipment company in the world. They are assisting us in all aspects of the project from facility design to equipment and training. With Precision’s help, the aim is to optimize the extraction process for the production of the world’s finest CBD isolate for the cosmetic and pharmaceutical market,” said Sergio Martines, CEO of Canapar.
The cGMP-compliant Ragusa facility is initially expected to be able to process over 600 tons of hemp biomass per year, making it the largest extraction facility in the European Union. With Precision’s assistance, Canapar is planning on scaling its operation within the next 12-18 months to keep up with projected demand.
According to Marc Beginin, CEO of Precision, “We are thrilled to be working with the professionals at Canapar. Canapar is poised to be the leading CBD isolate provider in Europe. They asked us to produce a scalable extraction plant with speed-to-market top of mind. Our team will be ready to deliver the first phase in Sicily this summer.”
The market for hemp extraction solutions to produce CBD isolate is growing rapidly. “Indeed, the market is robust,” says Beginin, “with the passage of the 2018 Farm Bill in the US, and increased legality of hemp-derived products worldwide, it is estimated that the market for hemp extracts will grow to $22 billion by 2020.”
About Precision® Extraction Solutions
Precision® Extraction Solutions is the industry leader and most trusted brand in cannabis and hemp extraction equipment, technology, lab design, training and consulting.
Precision® extraction systems are world renowned for quality, safety and precise operation. Certified for use in all regulated US and EU jurisdictions, more award-winning extracts are made with Precision® than any other brand.
Precision’s multi-solvent extraction systems process 100 to over 100,000+ lbs of material per day, making Precision® the professional’s choice for commercial and scaled industrial operations.
For more information about Precision® Extraction Solutions visit:
SOURCE: Precision Extraction Solutions
Collaboration Between Andrew Alliance SA and Ziath Ltd Brings Sample Tracking to Andrew Automation
Sample tracking on Andrew automation brings added levels of traceability to a wide variety of low to medium throughout applications
Andrew Alliance S.A., the robotics company that is improving repeatability with an innovative approach to liquid handling with conventional laboratory pipettes, and technology company Ziath Ltd, today announced a collaboration agreement to integrate barcode reading into Andrew Alliance’s software package. Under the co-marketing agreement, Andrew Alliance’s will integrate Ziath’s DataPaq™ Mirage 2D barcode rack scanner and other devices with their OneLab software platform and associated hardware, bringing sample tracking capability to a large number of applications.
“These days’ most high value samples are labelled with either 1D or 2D barcodes, and these samples need to be tracked throughout workflows within the laboratory,” said Piero Zucchelli, CEO and founder of Andrew Alliance. “Many of our customers and partners have been asking for us to add this capability into the OneLab platform and by working with Ziath we are able to combine industry leading technology to do this.”
“We are very pleased to be working with an innovative partner such as Andrew Alliance and look forward to introducing our technology to a new range of customers. Ziath is committed to easy to use sample tracking system and first class customer support and this is why we identify Andrew Alliance as a natural fit for both organisations to co-operate,” said Neil Benn, Managing Director, Ziath Ltd.
This collaboration reflects both companies’ commitment to providing scientists with the tools and solutions that enable them to make strides in their respective fields, without the worry of the consequences associated with manual errors.
SOURCE Andrew Alliance SA
Global Health Care Leaders Back Aetion with $27 Million Strategic Investment
Sanofi, UCB, McKesson Ventures, and Horizon Health Services Endorse Aetion’s Vision for Real-World Evidence
Aetion, the health care technology company that delivers the real-world analytics and evidence platform needed to engage in value-based care, announced it has attracted strategic investment from global leaders in biopharma and health care services, including Sanofi, UCB, McKesson Ventures, and Horizon Health Services, Inc., a Blue Cross Blue Shield of New Jersey company — four new strategic shareholders that join Amgen Ventures, an earlier investor. Existing venture capital investors also participated in this round, including NEA, Flare Capital, and Lakestar.
The latest strategic capital infusion of $27 million reflects Aetion’s substantial growth in customer adoption over the past year. Coupled with its prior funding in early 2018, the investment caps the total Series B funding at $63 million. This brings Aetion’s total funding to $77 million since its 2015 launch. Investment funds will be applied to strengthen the Aetion Evidence Platform™, extending its reach in therapeutic area-related intelligence, outcomes-based contracting for payers, and advancing the acceptance of standards for real-world evidence around the globe.
“The time for real-world evidence is now,” said Carolyn Magill, Chief Executive Officer of Aetion. “We’re entering a new era in which nearly the entire health care ecosystem — from biopharma and regulators to payers and technology companies — recognizes the importance of using real-world evidence to reduce the time and cost to bring new therapies to market. This funding demonstrates that the industry’s leaders, who are using our technology to drive health care’s most critical decisions, view Aetion as a trusted partner vital to their long-term success.”
For Aetion, strategic backing from a sweep of biopharma, health care services, and payer organizations with investment capital reinforces its position as an unbiased thought-leader at the forefront of industry adoption of real-world evidence, and underscores growing confidence among its partners and clients in the Aetion Evidence Platform as the analytics tool of record.
“We are at an inflection point, in which the convergence of massive analytical advances and enormous amounts of new data are transforming what’s possible in health care,” said Ameet Nathwani, M.D., Chief Medical Officer at Sanofi. “Aetion is ideally positioned to lead this shift, given the power of its technology and extensive experience with biopharma leaders and the FDA. Sanofi is excited to join as a strategic investor as the company helps set the global standards for real-world evidence.”
“Aetion’s abilities represent the leading edge of member-centric, value-based care,” said Bill Georges, Chief Strategy Officer at Horizon Healthcare Services, Inc. “Horizon has successfully deployed Aetion’s analytics and leveraged real-world evidence to determine which treatments are most effective for specific patient populations with diabetes. Horizon shares this data with our members’ doctors to help them deliver more effective treatment regimens that work to improve outcomes for our members and reduce their overall cost of care. We are thrilled to be collaborating with Aetion as a strategic investor and excited to expand the number of Horizon members who will benefit directly from Aetion’s innovation.”
Aetion is coming off a year of strong growth, and this funding continues the company’s momentum. Today, the Aetion Evidence Platform is used by eight of the top 15 global biopharma firms, leading payers, academic institutions, the U.S. Food and Drug Administration (FDA) and other major international regulatory bodies. Since 2017, it has seen a 100 percent customer renewal rate.
“Aetion shares our ambition to transform the future for people living with severe diseases, and our passion for science-driven approaches that serve this goal,” said Iris Loew-Friedrich, M.D., Ph.D., chief medical officer at UCB. “Aetion’s transparent evidence serves as a bridge between UCB and its payers, enabling us to apply real-world evidence to engage them in new ways. We’re thrilled to build upon our strong relationship with Aetion as a strategic investor.”
Also in 2018, Aetion began a partnership with the FDA to recreate 30 randomized clinical trials through real-world evidence, to demonstrate its value as an accelerant to drug approval and access decisions. The three-year study, named DUPLICATE, is referenced in the FDA’s recently released Framework for its Real-World Evidence Program, which applies across its drug and biologic review programs — yet another clear signal that real-world evidence will modernize how treatments are developed, approved, and commercialized.
“Aetion is poised to be the partner of choice for biopharma companies, payers and regulators looking to leverage real-world evidence given its unique relationships across the health care ecosystem and its expertise in protocols and treatment-based analytics,” said Tom Rodgers, SVP and Managing Director at McKesson Ventures.
To learn more, visit Aetion’s website and subscribe to its newsletter at www.aetion.com.
Subscribe to PICANTE via Email
Follow us on Facebook
Footprint Media Holdings Launches Bizz, a New Social Media App Designed to Boost Business
EU budget for 2021-2027: Commission welcomes provisional agreement on the future European Defence Fund
Infringements: Commission adapts its calculation methodology for financial sanctions
Iraq: EU announces additional €50 million in humanitarian aid and development cooperation
Vivo Brings Cutting-Edge Elevating Front Camera to V15Pro, Revving Up the Mobile Experience for Consumers Globally
Concur and Salesforce Alumni launch SalesTrip: the first platform to derive ROI from business travel and set to challenge the travel and expenses technology market
AUTOTECH 2018 – 100 M&A DEALS AND RECORD VENTURE CAPITAL INVESTMENT LAY THE FOUNDATIONS FOR AUTOMOTIVE FUTURE
Zenabis to Supply Premium Recreational Cannabis to Alberta
Will Bagley to Receive Western Writers of America’s Owen Wister Award
Wirecard and Tirol Werbung Launch Joint China Pay Initiative
World Blockchain Summit to enter Malaysia
Vitalik Buterin to Keynote World’s First Ethereum SuperMeetup in Hong Kong
Essilor India Unveils Crizal Sapphire 360° UV Lenses for Millennial
One in Four Consumers Stopped Doing Business with Companies Due to Lack of Personalized Communications
Kreative Kustomz 305 Debuts Unique New Bag Secured Apparel Collection
Fourth Annual Advisor Authority Study Profiles Unique Needs of Millennials to Help RIAs and Fee-Based Advisors Engage with Expanding Market of Emerging Investors
GrooveNexus – An Artist-fan Digital Music-place Launched in New Delhi
Gabriella’s Kitchen Announces Joint Venture with Eximius Coffee LLC to Introduce Cannabis and CBD-Infused Ready to Drink Cold Brew Coffee and Pods
Global Payment Processor Veem Introduces First and Only Rewards Program for International Payments to Celebrate 100,000th Customer
New eToro Survey: Nearly Half of Millennials Trust U.S. Stock Market Less Than Crypto
BitGo To Support TRON Currency
Former Virgin America Exec Porter Gale Joins Personal Capital as CMO
Millennials Will Drive Long-Term Residential New Construction, Easing Downturn Fears
VIZ Media Unveils THE WORLD NEXT DOOR
MSI Unveils Their New Gaming Laptop Line-up in India With the Latest NVIDIA® GeForce RTX™
Rolls Royce and Tudor Tech sign up to the Defence Aviation Safety Conference
Alfred Street Baptist Church Awards Howard University $100K To Pay Off Student Tuition and Fee Balances
The HistoryMakers Kicks Off Black History Month on PBS
Wirecard Enables Mobile Payments via Alipay at Stockmann, the Leading Luxury Fashion Department Store Chain in the Baltics
TrueCar Receives Two “Top Rated” DrivingSales Dealer Satisfaction Awards
David Beckham’s luxury men’s grooming brand HOUSE 99 is celebrating its first anniversary
750,000+ Celebrate the Future of the Mobility Industry at 2019 NAIAS
Gubagoo Wins “Top Rated” DrivingSales Dealer Satisfaction Award for Fourth Consecutive Year
Plant-Based Foods of Canada Welcomes Canada Food Guide Focus on Plant-based Proteins
Spotlight Labs Introduces SPYDR® Hypoxia Sensor Device
Malaysia Halal Expo 2019 (MHE 2019) Targets Tokyo Olympics
Global campaign offers Pope Francis $1 million to try vegan for Lent to save the planet
Second IFL Team Adopts Imagination Park’s Augmented Reality Solution
Adventure Awaits At Upscale Boutique Hotel Near Rocky Mountain National Park
Mytaste Group AB signs agreement with, igaming affiliate supplier voonix.net
Don Morphy Wins 2019 Fashion Group International Rising Star Award In Menswear
Community Brands Supports Florida Technology and Innovation at Synapse Summit
Sentry Energy Solutions Acquires Himarc Environmental Solutions
Emmy Nominated, National Geographic filmmaker joins blockchain group PO8
The Power Of The Bagel: Go Dairy-Free At Einstein Bros. Bagels
New Study by Schneider Electric Reveals Tangible Benefits for Businesses and Organisations Globally When They Lead With Digital Transformation in Energy Management and Automation
Malta AI & Blockchain Summit throwing massive show in May
Show The World Who You Are
Grand Opening of Unique Temple in India
Corcentric Named a Leader in IDC MarketScape Worldwide SaaS and Cloud-Enabled Accounts Payable Applications 2019
Follow our Tweets
European Commission Press Releases5 days ago
Digital Single Market: EU negotiators agree to set up new European rules to improve fairness of online platforms’ trading practices
Beverages6 days ago
Ben & Jerry’s Cookie Dough Ice Cream Goes Vegan
Asia6 days ago
Industry Leaders to Converge in Hong Kong to Discuss Digital Assets and Blockchain Applications at the HashKey International Digital Asset Summit 2019
Computer Electronics6 days ago
Cerebri AI Partners with Microsoft on Prescriptive Customer Analytics for Fortune 500
Biotechnology6 days ago
Breaking Ground on Europe’s Largest Hemp Extraction Facility
Latest News5 days ago
T-Mobile Austria deploys TEOCO’s SmartCM to improve network operations
Computer Electronics6 days ago
QuickLogic Launches the EOS S3AI SoC Platform for Time Series IoT Endpoint Applications
Banking & Financial Service5 days ago
Bitstop Unveils Next Generation Bitcoin ATM at EuroCIS Conference